Hrt Financial LP Sarepta Therapeutics, Inc. Transaction History

Hrt Financial LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$93.7 - $141.53 $2.45 Million - $3.7 Million	26,126 Added 343.22%	33,738 $4.37 Million
Q4 2023 Feb 09, 2024	BUY	$67.31 - $124.76 $512,363 - $949,673	7,612 New	7,612 $734,000
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $4.05 Million - $5.37 Million	34,456 Added 81.37%	76,799 $10.6 Million
Q4 2022 Feb 10, 2023	BUY	$100.86 - $132.13 $4.27 Million - $5.59 Million	42,343 New	42,343 $5.49 Million
Q2 2022 Aug 12, 2022	BUY	$62.69 - $88.44 $3.62 Million - $5.11 Million	57,771 New	57,771 $4.33 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $1.02 Million - $1.46 Million	-16,124 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $1.25 Million - $1.6 Million	16,124 New	16,124 $1.45 Million
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $222,746 - $520,872	-3,083 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $387,101 - $551,055	3,083 New	3,083 $525,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.